“Welcome to the psychedelic twenties.”
This is how Rick Doblin, founder and president of the Multidisciplinary Association for Psychedelic Studies (Maps), greeted a packed crowd on the opening morning of Psychedelic Science 2023 in Denver last week, dressed in a loose white suit befitting a guru. Billed as the largest-ever gathering of its kind — more than 12,000 attendees, according to Doblin — the conference brought together scientists, therapists, activists, entrepreneurs, and creatives bound together by what more than one speaker referred to as a mycelial network, or the threads that connect a collective fungal organism.
This is how Rick Doblin, founder and president of the Multidisciplinary Association for Psychedelic Studies (Maps), greeted a packed crowd on the opening morning of Psychedelic Science 2023 in Denver last week, dressed in a loose white suit befitting a guru. Billed as the largest-ever gathering of its kind — more than 12,000 attendees, according to Doblin — the conference brought together scientists, therapists, activists, entrepreneurs, and creatives bound together by what more than one speaker referred to as a mycelial network, or the threads that connect a collective fungal organism.
- 6/27/2023
- by Miles Klee
- Rollingstone.com
Not long after the polls closed in Denver on Tuesday night, news outlets were reporting that the nation’s first citywide initiative to decriminalize psilocybin mushrooms had failed. Disappointment washed over the psychonaut community on social media — the initiative, reports were saying, had lost by 3%. Meanwhile, at least 25% of the votes were still untallied and Decriminalize Denver Field Coordinator Travis Tyler Fluck announced he was “viciously optimistic.” It wasn’t for nothing.
As the final ballots were tallied, the initiative narrowly won on Wednesday, by less than 2,000 votes. The passage of Initiative 301 makes the possession,...
As the final ballots were tallied, the initiative narrowly won on Wednesday, by less than 2,000 votes. The passage of Initiative 301 makes the possession,...
- 5/11/2019
- by Shelby Hartman
- Rollingstone.com
For the first time in U.S. history, a psychedelic drug is on the fast track to getting approved for treating depression by the federal government. Late last month, Compass Therapeutics, a U.K.-based company that researches and develops mental health treatments, announced the Fda granted them what’s called a “breakthrough therapy designation” for their trials into psilocybin, the psychoactive ingredient in psychedelic mushrooms.
Researchers who pioneered psychedelic science agree — this is a landmark moment for their field.
“It really does represent a significant development in the whole history of psychedelic research,...
Researchers who pioneered psychedelic science agree — this is a landmark moment for their field.
“It really does represent a significant development in the whole history of psychedelic research,...
- 11/9/2018
- by Shelby Hartman
- Rollingstone.com
Albert Hofmann, the Swiss chemist who invented LSD, died Tuesday at home in Basel, Switzerland. He was 102. Rick Doblin, founder and president of the Multidisciplinary Association for Psychedelic Studies, told the New York Times that the cause of death was a heart attack. Hofmann synthesized the psychedelic drug in 1938, but didn't realize its other effects until five years later when he accidentally ingested the substance that would become known as acid during the 1960s. He proceeded to ingest LSD hundreds of times, but warned that it was a powerful drug that "demanded" respect, according to the Times. He valued its ability to apparently help people better understand humanity's relationship with...
- 3/19/2015
- E! Online
IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news articles, Tweets, and blog posts do not represent IMDb's opinions nor can we guarantee that the reporting therein is completely factual. Please visit the source responsible for the item in question to report any concerns you may have regarding content or accuracy.